- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 13, 2024 | 7.42M sh |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $564.71K |
| Cash And Equivalents | Q3 2024 · Jun 30, 2023 | $889.67K |
| Cash And Equivalents | Q3 2024 · Mar 31, 2023 | $544.32K |
| Cash And Equivalents | Q3 2024 · Jun 30, 2022 | $593.87K |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $2.63M |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $2.85M |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $2.92M |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $3.37M |
| Current Assets | Q3 2024 · Mar 31, 2024 | $4.15M |
| Current Assets | Q3 2024 · Jun 30, 2023 | $4.64M |
| Total Assets | Q3 2024 · Mar 31, 2024 | $4.6M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $5.31M |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 13.48M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 13.48M sh |
| Capex | Q3 2024 · Mar 31, 2023 | $6.69K |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | −$29.78K |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $1.74M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $1.15M |
| Stockholders Equity | Q3 2024 · Sep 30, 2022 | $1.16M |
| Stockholders Equity | Q3 2024 · Jun 30, 2022 | $1.48M |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | $0.04 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | $0.02 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | $0.08 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | $0.03 |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $938.16K |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $3.11M |
| Rd Expense | Q3 2024 · Mar 31, 2023 | $185.75K |
| Rd Expense | Q3 2024 · Mar 31, 2023 | $641.32K |
| Net Income | Q3 2024 · Mar 31, 2023 | $585.24K |
| Net Income | Q3 2024 · Mar 31, 2023 | $258.47K |
| Net Income | Q3 2024 · Dec 31, 2022 | −$6.04K |
| Net Income | Q3 2024 · Sep 30, 2022 | −$320.72K |
| Operating Income | Q3 2024 · Mar 31, 2023 | $589.55K |
| Operating Income | Q3 2024 · Mar 31, 2023 | $273.66K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $1.72M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $5.02M |